Active surveillance for low-risk prostate cancer: What do we still need to know?
Poster Session 60
-
Location:Room Madrid, North Hall (Level 1)
-
Chairs:
-
Aims and objectives of this session The aim of this session is to highlight lights and shadows of active surveillance and how to improve current protocols
- Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes in length, followed by 2 minutes for discussion. Extended presentations (*) are 3 minutes in length, followed by 3 minutes for discussion.
Institutes: 1University of Helsinki, University of Helsinki, Institute for Molecular Medicine Finland, Helsinki, Finland, 2University of Helsinki, Dept. of Urology, Helsinki, Finland, 3University of Helsinki, Institute for Molecular Medicine Finland, Dept. of Pathology, Helsinki, Finland
Institutes: 1Brigham and Women’s Hospital, Division of Urologic Surgery and Center For Surgery and Public Health, Boston, United States of America, 2Tan Tock Seng Hospital, Dept. of Urology, Singapore, Singapore, 3Marien Hospital Herne, Ruhr-University Bochum, Dept. of Urology, Herne, Germany, 4Henry Ford Health System, VUI Center for Outcomes Research, Analytics and Evaluation, Vattikuti Urology Institute, Detroit, United States of America
Institutes: 1University of Helsinki, Institute for Molecular Medicine Finland, Helsinki, Finland, 2University of Helsinki, Dept. of Urology, Helsinki, Finland, 3University of Helsinki, Dept. of Pathology, Institute for Molecular Medicine Finland, Helsinki, Finland
Institutes: 1Erasmus MC, Dept. of Public Health, Rotterdam, The Netherlands, 2Erasmus MC, Dept. of Urology, Rotterdam, The Netherlands
Institutes: 1Vita-Salute University San Raffaele, Dept. of Urology, Milan, Italy, 2Vita-Salute University San Raffaele, Dept. of Pathology, Milan, Italy
Institutes: 1Institute of Clinical Sciences, Sahlgrenska Academy At The University of Göteborg, Dept. of Urology, Gothenburg, Sweden, 2Institute of Clinical Sciences, Sahlgrenska Academy At The University of Gothenburg, Dept. of Urology, Gothenburg, Sweden
Institutes: 1Fondazione IRCCS Istituto Nazionale Tumori, Prostate Cancer Program, Milan, Italy, 2Fondazione IRCCS Istituto Nazionale Tumori, Dept. of Urology, Milan, Italy, 3Fondazione IRCCS Istituto Nazionale Tumori, Dept. of Radiation Oncology , Milan, Italy, 4Fondazione IRCCS Istituto Nazionale Tumori, Dept. of Radiation Oncology, Milan, Italy, 5Fondazione IRCCS Istituto Nazionale Tumori, Dept. of Anatomo-Pathology, Milan, Italy, 6Fondazione IRCCS Istituto Nazionale Tumori, Dept of. Radiology, Milan, Italy, 7Università Degli Studi Di Milano & Fondazione IRCCS Istituto Nazionale Tumori, Dept. of Hematology and Hemato-Oncology & Prostate Cancer Program & Radiation Oncology , Milan, Italy
Institutes: 1Ruhr-University Bochum, Marien Hospital Herne, Dept. of Urology, Herne, Germany, 2Center For Outcomes Research, Analytics and Evaluation, Vattikuti Urology Institute, Henry Ford Hosp, Dept. of Urology, Detroit, United States of America, 3Henry Ford Hospital, Dept. of Public Health Sciences, Detroit, United States of America, 4Maine Medical Center, Division of Urology & Center For Outcomes Research, Portland, United States of America, 5University Medical Center Hamburg-Eppendorf, Dept. of Urology, Hamburg, United States of America, 6Center For Surgery and Public Health, Brigham and Women’s Hospital, Division of Urology, Boston, United States of America
Institutes: 1Vita-Salute University San Raffaele, Dept. of Urology, Milan, Italy, 2Vita-Salute University San Raffaele, Dept. of Radiology, Milan, Italy, 3Vita-Salute University San Raffaele, Dept. of Pathology, Milan, Italy
Institutes: 1Oxford University Hospitals Nhs Foundation Trust, Dept. of Urology, Oxford, United Kingdom, 2Oxford University Hospitals Nhs Foundation Trust, Dept. of Radiology, Oxford, United Kingdom, 3Oxford University Hospitals Nhs Foundation Trust, Dept. of Pathology, Oxford, United Kingdom
Institutes: 1University College London Hospital, Dept. of Radiology, London, United Kingdom, 2University College London Hospital, Dept. of Urology, London, United Kingdom
To be confirmed